Showing results (201-210 of 293) with videos related to

Sort By:
Pageof 30
Animal Reproduction|August 23, 2024
Foal sex in Thoroughbred horses: related factorsJonas Gomes Flores, Verônica La Cruz Bueno, Henrique Boll de Araujo Bastos, et al.
Theriogenology|November 25, 2019
The mule (Equus mulus) as a recipient of horse (Equus caballus) embryos: Comparative aspects of early pregnancy with maresC E Camargo, S Fiala Rechsteiner, R C Macan, et al.
Nature|December 24, 1997
Structure of the proteasome activator REGalpha (PA28alpha)J R Knowlton, S C Johnston, F G Whitby, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2014
Intratumor heterogeneity in hepatocellular carcinomaJuliane Friemel, Markus Rechsteiner, Lukas Frick, et al.
Frontiers in Molecular Neuroscience|June 10, 2017
The 11S Proteasomal Activator REGγ Impacts Polyglutamine-Expanded Androgen Receptor Aggregation and Motor Neuron Viability through Distinct MechanismsJill M Yersak, Heather L Montie, Erica S Chevalier-Larsen, et al.
Oncotarget|June 6, 2019
Melanoma patients with additional primary cancers: a single-center retrospective analysisFlorentia Dimitriou, Joanna Mangana, Alessandra Curioni-Fontecedro, et al.
Experimental and Molecular Pathology|August 23, 2013
TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous typeMarkus Rechsteiner, Anne-Katrin Zimmermann, Peter J Wild, et al.
Plos One|June 7, 2014
Automated assessment of β-cell area and density per islet and patient using TMEM27 and BACE2 immunofluorescence staining in human pancreatic β-cellsMarkus P Rechsteiner, Xenofon Floros, Bernhard O Boehm, et al.
Targeted Oncology|September 22, 2022
Mutational Landscape and Expression of PD-L1 in Patients with Non-Small Cell Lung Cancer Harboring Genomic Alterations of the MET geneAlessa Fischer, Lorenz Bankel, Stefanie Hiltbrunner, et al.
The Annals of Thoracic Surgery|July 6, 2000
Prognostic relevance of Masaoka and Müller-Hermelink classification in patients with thymic tumorsD Lardinois, R Rechsteiner, R H Läng, et al.
Pageof 30